JANX
Price
$25.96
Change
-$0.01 (-0.04%)
Updated
Jul 25 closing price
Capitalization
1.54B
16 days until earnings call
TARA
Price
$3.33
Change
-$0.01 (-0.30%)
Updated
Jul 25 closing price
Capitalization
128.48M
15 days until earnings call
Interact to see
Advertisement

JANX vs TARA

Header iconJANX vs TARA Comparison
Open Charts JANX vs TARABanner chart's image
Janux Therapeutics
Price$25.96
Change-$0.01 (-0.04%)
Volume$1.32M
Capitalization1.54B
Protara Therapeutics
Price$3.33
Change-$0.01 (-0.30%)
Volume$111.67K
Capitalization128.48M
JANX vs TARA Comparison Chart in %
Loading...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JANX vs. TARA commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JANX is a Hold and TARA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (JANX: $25.96 vs. TARA: $3.33)
Brand notoriety: JANX and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JANX: 169% vs. TARA: 34%
Market capitalization -- JANX: $1.54B vs. TARA: $128.48M
JANX [@Biotechnology] is valued at $1.54B. TARA’s [@Biotechnology] market capitalization is $128.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JANX’s FA Score shows that 0 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • JANX’s FA Score: 0 green, 5 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, TARA is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JANX’s TA Score shows that 6 TA indicator(s) are bullish while TARA’s TA Score has 5 bullish TA indicator(s).

  • JANX’s TA Score: 6 bullish, 4 bearish.
  • TARA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, JANX is a better buy in the short-term than TARA.

Price Growth

JANX (@Biotechnology) experienced а -1.67% price change this week, while TARA (@Biotechnology) price change was +8.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

JANX is expected to report earnings on Aug 12, 2025.

TARA is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($1.54B) has a higher market cap than TARA($128M). TARA YTD gains are higher at: -36.932 vs. JANX (-51.513). TARA has higher annual earnings (EBITDA): -51.1M vs. JANX (-111.54M). JANX has more cash in the bank: 1.01B vs. TARA (124M). TARA has less debt than JANX: TARA (4.23M) vs JANX (22.6M). JANX has higher revenues than TARA: JANX (9.34M) vs TARA (0).
JANXTARAJANX / TARA
Capitalization1.54B128M1,200%
EBITDA-111.54M-51.1M218%
Gain YTD-51.513-36.932139%
P/E RatioN/AN/A-
Revenue9.34M0-
Total Cash1.01B124M818%
Total Debt22.6M4.23M535%
FUNDAMENTALS RATINGS
TARA: Fundamental Ratings
TARA
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JANXTARA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBMFF0.380.02
+4.68%
NEO Battery Materials Ltd.
PGPKY6.45N/A
N/A
PGE Polska Energetyczna SA
SWGNF37.90N/A
N/A
Swatch Group AG
ALSUF2.00N/A
N/A
Alpha Star Acquisition Corporation
CGECF45.47-0.53
-1.15%
Cogeco Inc.

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with CRNX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
-0.04%
CRNX - JANX
39%
Loosely correlated
N/A
IDYA - JANX
38%
Loosely correlated
-1.33%
SYRE - JANX
38%
Loosely correlated
+1.08%
APGE - JANX
37%
Loosely correlated
-1.97%
TERN - JANX
37%
Loosely correlated
N/A
More

TARA and

Correlation & Price change

A.I.dvisor tells us that TARA and ITRM have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TARA and ITRM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
-0.30%
ITRM - TARA
32%
Poorly correlated
-2.73%
CDIO - TARA
31%
Poorly correlated
-4.21%
RNXT - TARA
30%
Poorly correlated
-2.31%
JANX - TARA
29%
Poorly correlated
-0.04%
CRNX - TARA
28%
Poorly correlated
N/A
More